Axert
NDC Package 50458-211-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Axert is a . Marketed by Janssen Pharmaceuticals, Inc., this product is identified by NDC 50458-211 and is authorized under FDA application NDA021001.

Identification & Billing

NDC Package Code
50458-211-01
Package Description
6 TABLET, COATED in 1 BLISTER PACK
Product Code
50458-211
11-Digit Billing Format
50458021101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
6 EA

Clinical Specifications

Proprietary Name
Axert
Dosage Form
-

Regulatory & Marketing

Labeler Name
Janssen Pharmaceuticals, Inc.
FDA Application #
NDA021001
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-07-2001
End Marketing Date
06-15-2020
Listing Expiration
06-15-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50458-211-01 identifies a specific commercial package of 6 tablet, coated in 1 blister pack of Axert, labeled by Janssen Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Janssen Pharmaceuticals, Inc. on May 07, 2001. The current certification is valid through June 15, 2020.

How is this Janssen Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50458021101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50458-211-01
11-Digit CMS (5-4-2)
50458-0211-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.